Dr. Saghi Ghaffari, MD, PhD Professor of Cell, Developmental & Regenerative Biology Icahn School of Medicine at Mount Sinai Dr. Saghi Ghaffari received her first NYSTEM (New York Stem Cell Science Program) award in 2008, when she was working with embryonic stem cells to identify factors that might regulate the cells’ pluripotent properties (their ability… Read More
Dimitris G. Placantonakis, MD, PhD NYU School of Medicine Assistant Professor, Department of Neurosurgery Director Neurosurgical Laboratory for Stem Cell Research Dr. Dimitris G. Placantonakis is a physician-scientist—he both removes and researches a specific type of brain tumor, called low-grade gliomas. There are an estimated 20,000 cases of gliomas every year in the U.S., up… Read More
Highlights Columbia University Vagelos College of Physicians and Surgeons: Five Stem Cell Projects Funded by NYSTEM Five projects led by researchers at the Columbia University Vagelos College of Physicians and Surgeons have been funded by the New York State Stem Cell Science program (NYSTEM) through Investigator Initiated Research Projects and Innovative, Developmental or Exploratory Activities… Read More
Erika Bach, PhD NYU School of Medicine, Associate Professor, Department of Biochemistry and Molecular Pharmacology Stem cells are often considered the future of medicine, but much is still unknown about how they work. That’s why Dr. Erika Bach and her team are closely studying basic, universal properties of stem cells. They are working to identify the… Read More
By Nick Niedzwiadek 02/05/2018 06:37 PM EDT ALBANY — Stem cell researchers touted the results of New York’s decade of investment in their work Monday and advocated for a critical funding program’s continued existence. The New York State Stem Cell Science program, a $600 million initiative, began in 2007 under then-Gov. Eliot Spitzer. Supporters laud… Read More
STEM CELL RESEARCH STATUS CHECK By Capital Tonight Staff | February 5, 2018 @8:22 PM SHARE New York Stem Cell Science awards support research into things like blood disorders, cancer, or the Zika virus. And it all started with a $600 million investment back in 2007. Monday, researchers gave lawmakers an update on some of the work… Read More
Dr. Todd Evans, Ph.D. Weill Cornell Medicine Associate Dean for Research Peter I. Pressman, M.D. Professor in Surgery In 2017, Dr. Todd Evans and his colleagues published pioneering research on their development of the first-ever human tissue platform to test drugs for colon cancer. Using a “disease in a Petri dish” model derived from stem… Read More
In 2009, a $3.6 million grant by New York State Stem Cell Science (NYSTEM) established the Western New York Stem Cell Culture and Analysis Center at the University at Buffalo. The establishment of this shared-use research facility allows access to critical equipment used not only by medical school faculty, but researchers in pharmacology, biology, chemistry,… Read More
Breast cancer affects approximately 1 in 8 women in the U.S. In 2017, it’s estimated that about 30% of newly diagnosed cancers in women will be breast cancers. While prognoses have improved in recent decades, thanks to advances in biomedical research leading to new and improved treatments, there remains work to be done. This work… Read More
Sally Temple, PhD Neural Stem Cell Institute, Scientific Director, Principal Investigator and Co-Founder; University at Albany, Professor in the Department of Biomedical Sciences; Albany Medical College, Professor of Neuroscience and Experimental Therapeutics Age-related Macular Degeneration (AMD) is the leading cause of blindness, affecting 1 in 5 people over the age of 75. As AMD progresses, patients… Read More
